Pimicotinib in cGVHD
Phase II Trial of Pimicotinib, a CSF-1R Inhibitor, for Previously Treated Chronic GVHD

Released: December 10, 2024

Expiration: December 09, 2025

Activity

Progress
1
Course Completed